Difference between revisions of "LoConte NK, et al. Invest. N. Drugs (2015) cited as Ref 590 in DOI: 10.1038/s41392-020-0110-5 (Q9853)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2015, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): Invest. N. Drugs, #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | Invest. N. Drugs | ||
| Property / Published In Name String: Invest. N. Drugs / rank | |||
| + | Normal rank | ||
Revision as of 21:06, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
LoConte NK, et al. Invest. N. Drugs (2015) cited as Ref 590 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
LoConte NK
0 references
2015
0 references
Invest. N. Drugs
0 references
